专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20080162915A1 SELF-HEALING COMPUTING SYSTEM 审中-公开
标题翻译：自我治疗计算系统
公开(公告)号：US20080162915A1
公开(公告)日：2008-07-03
申请号：US11618554
申请日：2006-12-29
申请人： Mark H. Price , Jim S. Baca , Nicholas Woo , Yiming Yang , Ajith K. Illendula
发明人： Mark H. Price , Jim S. Baca , Nicholas Woo , Yiming Yang , Ajith K. Illendula
IPC分类号： G06F15/177
CPC分类号： G06F21/57 , G06F21/568
摘要： Methods and apparatus for software recovery in a computing system are disclosed. Software installation is authorized, for example, by a user providing a password or a finger print or some other authorization mechanism. The software may then be installed to a flash memory drive. Write access to the flash memory drive is disabled upon completion of the software installation to the flash memory drive. The software is also installed to a system hard drive. If any files of the software installation become corrupted on the hard drive, the corrupted files may be restored from corresponding uncorrupted files of the software installation on the flash memory drive. Restoring the corrupted files may be accomplished by rebooting into a pre-boot BIOS mode and then authorizing the BIOS to remove the corrupted files and to replace them with a copy of the uncorrupted files from the flash memory drive.
摘要翻译：公开了用于计算系统中的软件恢复的方法和装置。例如，软件安装由用户提供密码或指纹或其他授权机制授权。然后软件可以安装到闪存驱动器。完成对闪存驱动器的软件安装后，对闪存驱动器的写入访问被禁用。该软件也安装到系统硬盘驱动器。如果软件安装的任何文件在硬盘驱动器上损坏，则可能会从闪存驱动器上软件安装的相应未破坏的文件恢复损坏的文件。恢复损坏的文件可能会通过重新启动到预引导BIOS模式，然后授权BIOS删除损坏的文件并将其替换为闪存驱动器中的未损坏文件的副本来实现。

2. 发明申请

US20080077727A1 Multithreaded state machine in non-volatile memory devices 审中-公开
标题翻译：多线程状态机在非易失性存储器件中
公开(公告)号：US20080077727A1
公开(公告)日：2008-03-27
申请号：US11526360
申请日：2006-09-25
申请人： Jim S. Baca , Nicholas Woo , Mark Price , Yiming Yang
发明人： Jim S. Baca , Nicholas Woo , Mark Price , Yiming Yang
IPC分类号： G06F12/00
CPC分类号： G06F9/4881 , G06F2209/484
摘要： Various embodiments allow a non-volatile memory device to manage multiple process requests from an associated computing device. In at least some embodiments, a multi-threaded state machine is included in the supporting logic of the non-volatile memory device. Multiple process requests are received by the non-volatile memory device and serviced in a multi-threaded fashion.
摘要翻译：各种实施例允许非易失性存储器设备管理来自相关联的计算设备的多个处理请求。在至少一些实施例中，多线程状态机被包括在非易失性存储器件的支持逻辑中。多个处理请求由非易失性存储器件接收并以多线程方式服务。

3. 发明授权

US10858581B2 Heterojunctions in halide perovskite nanostructures 有权
公开(公告)号：US10858581B2
公开(公告)日：2020-12-08
申请号：US15727823
申请日：2017-10-09
申请人： Letian Dou , Minliang Lai , Yiming Yang , Peidong Yang
发明人： Letian Dou , Minliang Lai , Yiming Yang , Peidong Yang
IPC分类号： C30B29/12 , C09K11/66 , B82Y40/00 , B82Y30/00
摘要： This disclosure provides systems, methods, and apparatus related to heterojunctions in halide perovskite nanostructures. In one aspect, a nanostructure comprises a first region and a second region. The first region comprises ABX3, with A being selected from a group consisting of Cs and Rb, with B being selected from a group consisting of Sn and Pb, and with X being selected from a group consisting of Br, Cl, and Br and Cl. The second region comprises ABY3, with Y being selected from a group consisting of Br, I, and Br and I. Compositions of the first region of the nanostructure and the second region of the nanostructure are different.

4. 发明申请

US20180105743A1 HETEROJUNCTIONS IN HALIDE PEROVSKITE NANOSTRUCTURES 审中-公开
公开(公告)号：US20180105743A1
公开(公告)日：2018-04-19
申请号：US15727823
申请日：2017-10-09
申请人： Letian Dou , Minliang Lai , Yiming Yang , Peidong Yang
发明人： Letian Dou , Minliang Lai , Yiming Yang , Peidong Yang
IPC分类号： C09K11/66
CPC分类号： C09K11/665
摘要： This disclosure provides systems, methods, and apparatus related to heterojunctions in halide perovskite nanostructures. In one aspect, a nanostructure comprises a first region and a second region. The first region comprises ABX3, with A being selected from a group consisting of Cs and Rb, with B being selected from a group consisting of Sn and Pb, and with X being selected from a group consisting of Br, Cl, and Br and Cl. The second region comprises ABY3, with Y being selected from a group consisting of Br, I, and Br and I. Compositions of the first region of the nanostructure and the second region of the nanostructure are different.

5. 发明申请

US20060142383A1 3D-Structure model of SARS coronavirus 3CL protease and anti-SARS drugs 失效
标题翻译： SARS冠状病毒3CL蛋白酶和抗SARS药物的3D结构模型
公开(公告)号：US20060142383A1
公开(公告)日：2006-06-29
申请号：US11293847
申请日：2005-12-02
申请人： Jianhua Shen , Hualiang Jiang , Xu Shen , Jianping Zuo , Xiaomin Luo , Donglu Bai , Jingkang Shen , Kaixian Chen , Chunshan Gui , Lili Chen , Jing Chen , Yifu Yang , Xianhan Zhuang , Yiming Yang , Xuchang He , Hong Liu , Bing Xiong , Haibin Luo , Tao Sun , Fei Ye
发明人： Jianhua Shen , Hualiang Jiang , Xu Shen , Jianping Zuo , Xiaomin Luo , Donglu Bai , Jingkang Shen , Kaixian Chen , Chunshan Gui , Lili Chen , Jing Chen , Yifu Yang , Xianhan Zhuang , Yiming Yang , Xuchang He , Hong Liu , Bing Xiong , Haibin Luo , Tao Sun , Fei Ye
IPC分类号： C12Q1/70 , G06F19/00 , C12N9/48 , A61K31/21 , A61K31/235 , A61K31/165
CPC分类号： C12N9/506 , A61K31/167
摘要： The present invention discloses 3D-structure of SARS-CoV Viral 3CL Protease obtained through molecular simulation. The 3D-structure is used as a drug target for screening the existing medical database CMC (Comprehensive Medicinal Chemistry, MDL Information System, Inc.), and a group of compounds which have the activity of inhibiting SARS-CoV virus 3CL Protease are found. Cinanserin was tested at molecular and viral levels, and it was found to be able to inhibit the SARS-CoV viral 3CL protease and SARS-CoV viruses. Cinanserin analogs were synthesized and tested at molecular and viral levels, they were found to be able to inhibit the SARS-CoV virus 3CL Protease and SARS-CoV viruses, and may be used for treating and/or preventing SARS-CoV virus infection.
摘要翻译：本发明公开了通过分子模拟获得的SARS-CoV病毒3CL蛋白酶的三维结构。使用3D结构作为筛选现有医学数据库CMC（Comprehensive Medicinal Chemistry，MDL Information System，Inc。）的药物靶点，并发现一组具有抑制SARS-CoV病毒3CL蛋白酶活性的化合物。在分子和病毒水平测试了Cinanserin，发现能够抑制SARS-CoV病毒3CL蛋白酶和SARS-CoV病毒。合成Cinanserin类似物并在分子和病毒水平进行测试，发现它们能够抑制SARS-CoV病毒3CL蛋白酶和SARS-CoV病毒，可用于治疗和/或预防SARS-CoV病毒感染。

6. 发明授权

US08395398B2 Method of characterizing particles 有权
标题翻译：表征颗粒的方法
公开(公告)号：US08395398B2
公开(公告)日：2013-03-12
申请号：US12766057
申请日：2010-04-23
申请人： Renliang Xu , Yiming Yang
发明人： Renliang Xu , Yiming Yang
IPC分类号： G01R27/08
CPC分类号： G01N15/1218 , G01N2015/1062 , G01N2015/1087
摘要： Mixtures containing homogeneously-sized particles with a minimum concentration of agglomerates or larger particles are desired in various manufacturing processes such as, for example, in the manufacture and use of chemical mechanical polishing slurries, food emulsions, pharmaceutical products, paints, and print toner. The method disclosed herein provides these industries with an accurate and efficient method of screening such mixtures for such agglomerates and large particles. The method generally includes preparing a suspension of the mixture in an electrolyte, wherein the suspension includes a specified concentration of small particles per unit of electrolyte. The method further includes passing the prepared suspension, and a plurality of the particles therein, through an aperture of a device capable of characterizing particles according to the Coulter principle to obtain data on the particles. Still further, the method includes deriving a particle size distribution of the large particles from the obtained data. The suspension includes at least one small particle per aperture volume. The large particles have an average diameter that is at least five times greater than the average diameter of the small particles. The aperture has a diameter that is (i) at least 50 times greater than the average diameter of the small particles, and (ii) about 1.2 times greater than the average diameter of the large particles to less than about 50 times greater than the average diameter of the large particles.
摘要翻译：在各种制造过程中，例如在制造和使用化学机械抛光浆料，食品乳剂，药物产品，油漆和印刷色调剂中期望含有具有最小浓度的附聚物或更大颗粒的均匀尺寸的颗粒的混合物。本文公开的方法为这些工业提供了精确和有效的筛选这种聚集体和大颗粒的混合物的方法。该方法通常包括制备混合物在电解质中的悬浮液，其中悬浮液包含每单位电解液中规定浓度的小颗粒。该方法还包括通过能够根据库尔特原理表征颗粒的装置的孔，将制备的悬浮液和其中的多个颗粒通过，以获得颗粒上的数据。此外，该方法包括从所获得的数据导出大颗粒的粒度分布。悬浮液包含每孔径体积至少一个小颗粒。大颗粒的平均直径比小颗粒的平均直径大至少五倍。孔径的直径为（i）比小颗粒的平均直径大至少50倍，和（ii）比大颗粒的平均直径大约比平均直径大约平均直径大约平均直径的约1.2倍直径大的颗粒。

7. 发明授权

US07662860B2 3D-structure model of SARS coronavirus 3CL protease and anti-SARS drugs 失效
标题翻译： SARS冠状病毒3CL蛋白酶和抗SARS药物的3D结构模型
公开(公告)号：US07662860B2
公开(公告)日：2010-02-16
申请号：US11293847
申请日：2005-12-02
申请人： Jianhua Shen , Hualiang Jiang , Xu Shen , Jianping Zuo , Xiaomin Luo , Donglu Bai , Jingkang Shen , Kaixian Chen , Chunshan Gui , Lili Chen , Jing Chen , Yifu Yang , Xianhan Zhuang , Yiming Yang , Xuchang He , Hong Liu , Bing Xiong , Haibin Luo , Tao Sun , Fei Ye
发明人： Jianhua Shen , Hualiang Jiang , Xu Shen , Jianping Zuo , Xiaomin Luo , Donglu Bai , Jingkang Shen , Kaixian Chen , Chunshan Gui , Lili Chen , Jing Chen , Yifu Yang , Xianhan Zhuang , Yiming Yang , Xuchang He , Hong Liu , Bing Xiong , Haibin Luo , Tao Sun , Fei Ye
IPC分类号： A61K31/165
CPC分类号： C12N9/506 , A61K31/167
摘要： The present invention discloses 3D-structure of SARS-CoV Viral 3CL Protease obtained through molecular simulation. The 3D-structure is used as a drug target for screening the existing medical database CMC (Comprehensive Medicinal Chemistry, MDL Information System, Inc.), and a group of compounds which have the activity of inhibiting SARS-CoV virus 3CL Protease are found. Cinanserin was tested at molecular and viral levels, and it was found to be able to inhibit the SARS-CoV viral 3CL protease and SARS-CoV viruses. Cinanserin analogs were synthesized and tested at molecular and viral levels, they were found to be able to inhibit the SARS-CoV virus 3CL Protease and SARS-CoV viruses, and may be used for treating and/or preventing SARS-CoV virus infection.
摘要翻译：本发明公开了通过分子模拟获得的SARS-CoV病毒3CL蛋白酶的三维结构。使用3D结构作为筛选现有医学数据库CMC（Comprehensive Medicinal Chemistry，MDL Information System，Inc。）的药物靶点，并发现一组具有抑制SARS-CoV病毒3CL蛋白酶活性的化合物。在分子和病毒水平测试了Cinanserin，发现能够抑制SARS-CoV病毒3CL蛋白酶和SARS-CoV病毒。合成Cinanserin类似物并在分子和病毒水平进行测试，发现它们能够抑制SARS-CoV病毒3CL蛋白酶和SARS-CoV病毒，可用于治疗和/或预防SARS-CoV病毒感染。

8. 发明申请

US20100271053A1 Method of Characterizing Particles 有权
标题翻译：颗粒表征方法
公开(公告)号：US20100271053A1
公开(公告)日：2010-10-28
申请号：US12766057
申请日：2010-04-23
申请人： Renliang Xu , Yiming Yang
发明人： Renliang Xu , Yiming Yang
IPC分类号： G01R27/08
CPC分类号： G01N15/1218 , G01N2015/1062 , G01N2015/1087
摘要： Mixtures containing homogeneously-sized particles with a minimum concentration of agglomerates or larger particles are desired in various manufacturing processes such as, for example, in the manufacture and use of chemical mechanical polishing slurries, food emulsions, pharmaceutical products, paints, and print toner. The method disclosed herein provides these industries with an accurate and efficient method of screening such mixtures for such agglomerates and large particles. The method generally includes preparing a suspension of the mixture in an electrolyte, wherein the suspension includes a specified concentration of small particles per unit of electrolyte. The method further includes passing the prepared suspension, and a plurality of the particles therein, through an aperture of a device capable of characterizing particles according to the Coulter principle to obtain data on the particles. Still further, the method includes deriving a particle size distribution of the large particles from the obtained data. The suspension includes at least one small particle per aperture volume. The large particles have an average diameter that is at least five times greater than the average diameter of the small particles. The aperture has a diameter that is (i) at least 50 times greater than the average diameter of the small particles, and (ii) about 1.2 times greater than the average diameter of the large particles to less than about 50 times greater than the average diameter of the large particles.
摘要翻译：在各种制造过程中，例如在制造和使用化学机械抛光浆料，食品乳剂，药物产品，油漆和印刷色调剂中期望含有具有最小浓度的附聚物或更大颗粒的均匀尺寸的颗粒的混合物。本文公开的方法为这些工业提供了精确和有效的筛选这种聚集体和大颗粒的混合物的方法。该方法通常包括制备混合物在电解质中的悬浮液，其中悬浮液包含每单位电解液中规定浓度的小颗粒。该方法还包括通过能够根据库尔特原理表征颗粒的装置的孔，将制备的悬浮液和其中的多个颗粒通过，以获得颗粒上的数据。此外，该方法包括从所获得的数据导出大颗粒的粒度分布。悬浮液包含每孔径体积至少一个小颗粒。大颗粒的平均直径比小颗粒的平均直径大至少五倍。孔径的直径为（i）比小颗粒的平均直径大至少50倍，和（ii）比大颗粒的平均直径大约比平均直径大约平均直径大约平均直径的约1.2倍直径大的颗粒。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式